Volume 34, 12 September 2003 09/2003
 
  SPOT ON
 

Candesartan (e.g. ATACAND) in heart failure?

Perindopril (COVERSUM) in coronary heart disease?

 
  NEW ON THE MARKET
 

Not at all new: Escitalopram (CIPRALEX)

 
  TREATMENT RECOMMENDATION
 

Long-term anticoagulation in idiopathic venous thromboembolism

 
  QUALITY ASSESSMENT
 

Hydrochlorothiazide and paracetamol preparations

 
  a-t READERS' QUESTIONS AND COMMENTS
 

GUKOKINE for diabetes?
Old registered drugs and what happens then
Proton pump inhibitor via PEG tube?
Expired drugs
ISCOVER/PLAVIX more expensive

 
  IN BRIEF
 

Beware of "drug holidays" in patients with multidrug-resistant HI virus
High-dose dexamethasone (e.g. FORTECORTIN) therapy
for idiopathic thrombopenia?
Chronic myeloid leukaemia: Survival with imatinib (GLIVEC)
Hot flushes: Phytoestrogens from red clover vs placebo

 
  CURRENT ADR NETWORK REPORT
 

Granulomas after intradermal injection of DERMALIVE

 
  SIDE EFFECTS
 

Bicalutamide (CASODEX) in patients with localized prostate cancer
Sibutramin (REDUCTIL): Market withdrawal warranted

 
© arznei-telegramm 09/2003